Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank71
3Y CAGR+21.5%
5Y CAGR-24.1%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

3Y CAGR
+21.5%/yr
Annual compound
5Y CAGR
-24.1%/yr
Recent acceleration
Percentile
P71
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive growthRecovering
PeriodValue
202549.12%
202442.00%
202316.51%
202227.36%
20214.03%
2020194.90%
20192341.02%
20180.00%